Annual Cash & Cash Equivalents
$35.10 M
-$45.72 M-56.57%
December 31, 2021
Summary
- As of February 10, 2025, YMTX annual cash & cash equivalents is $35.10 million, with the most recent change of -$45.72 million (-56.57%) on December 31, 2021.
- During the last 3 years, YMTX annual cash & cash equivalents has risen by +$21.08 million (+150.35%).
Performance
YMTX Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$8.42 M
-$3.43 M-28.95%
September 30, 2022
Summary
- As of February 10, 2025, YMTX quarterly cash and cash equivalents is $8.42 million, with the most recent change of -$3.43 million (-28.95%) on September 30, 2022.
- Over the past year, YMTX quarterly cash and cash equivalents has dropped by -$35.12 million (-80.67%).
Performance
YMTX Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
YMTX Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -56.6% | -80.7% |
| 3 y3 years | +150.3% | - |
| 5 y5 years | +150.3% | - |
YMTX Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | at low | -76.0% | at low |
| 5 y | 5-year | -56.6% | -60.1% | -89.6% | at low |
| alltime | all time | -56.6% | -60.1% | -89.6% | at low |
Yumanity Therapeutics Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | $8.42 M(-29.0%) |
| Jun 2022 | - | $11.85 M(-26.2%) |
| Mar 2022 | - | $16.06 M(-54.2%) |
| Dec 2021 | $35.10 M | $35.10 M(-19.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2021 | - | $43.53 M(-8.0%) |
| Jun 2021 | - | $47.33 M(-9.2%) |
| Mar 2021 | - | $52.11 M(-35.5%) |
| Dec 2020 | $80.82 M(+476.4%) | $80.82 M |
| Dec 2019 | $14.02 M | - |
FAQ
- What is Yumanity Therapeutics annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Yumanity Therapeutics?
- What is Yumanity Therapeutics annual cash & cash equivalents year-on-year change?
- What is Yumanity Therapeutics quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Yumanity Therapeutics?
- What is Yumanity Therapeutics quarterly cash and cash equivalents year-on-year change?
What is Yumanity Therapeutics annual cash & cash equivalents?
The current annual cash & cash equivalents of YMTX is $35.10 M
What is the all time high annual cash & cash equivalents for Yumanity Therapeutics?
Yumanity Therapeutics all-time high annual cash & cash equivalents is $80.82 M
What is Yumanity Therapeutics annual cash & cash equivalents year-on-year change?
Over the past year, YMTX annual cash & cash equivalents has changed by -$45.72 M (-56.57%)
What is Yumanity Therapeutics quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of YMTX is $8.42 M
What is the all time high quarterly cash and cash equivalents for Yumanity Therapeutics?
Yumanity Therapeutics all-time high quarterly cash and cash equivalents is $80.82 M
What is Yumanity Therapeutics quarterly cash and cash equivalents year-on-year change?
Over the past year, YMTX quarterly cash and cash equivalents has changed by -$35.12 M (-80.67%)